CAPhO 2026 Key Challenges in Funding High-Cost Cancer Drugs: Ethics, Affordability and Future Considerations

Concurrent Session

Dr. O’Rourke will describe the current system in Canada for conducting health technology assessments and price negotiation of cancer drugs. He will identify key challenges associated with the high cost of new cancer drugs and will present options for addressing the ethical and affordability challenges. Dr. O’Rourke will also identify major global trends that have the potential to impact the availability, access, and price of oncology drugs in Canada.